Rachel K. Bolognone
Papers
2
Total Citations
122
H-Index
2
About
Rachel K. Bolognone is a leading clinical researcher in head and neck oncology, with a specialized focus on transoral robotic surgery (TORS) for oropharyngeal cancer. Her work has fundamentally shaped how clinicians assess and improve patient outcomes following this minimally invasive procedure. Her landmark 2017 study on long-term functional and quality-of-life outcomes after TORS, cited over 90 times, provided critical evidence that in appropriately selected patients, TORS can allow for the avoidance of adjuvant chemotherapy and radiotherapy, thereby sparing patients from severe long-term adverse effects. Complementing this, Bolognone conducted a pioneering randomized controlled trial on the use of corticosteroids for pain management after TORS, demonstrating her commitment to refining perioperative care and enhancing patient recovery. With her research directly influencing surgical decision-making and postoperative protocols, Bolognone’s contributions are essential for any clinician or researcher working to optimize both oncologic control and quality of life in head and neck cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1
- 2